Cargando…
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
BACKGROUND: Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent whole genome studies revealed distinct mutations in several candidate oncogenes. While clinical parameters stratify osteosarcoma patients in risk groups...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527636/ https://www.ncbi.nlm.nih.gov/pubmed/34670578 http://dx.doi.org/10.1186/s13053-021-00202-0 |
_version_ | 1784586108272640000 |
---|---|
author | Puzik, Alexander Uhl, Markus Ruf, Juri Schumacher, Tilmann Kontny, Udo |
author_facet | Puzik, Alexander Uhl, Markus Ruf, Juri Schumacher, Tilmann Kontny, Udo |
author_sort | Puzik, Alexander |
collection | PubMed |
description | BACKGROUND: Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent whole genome studies revealed distinct mutations in several candidate oncogenes. While clinical parameters stratify osteosarcoma patients in risk groups, genetic profiles have not yet been used to tailor tumour treatment. However, specific copy number alterations seem to have a prognostic impact in osteosarcoma treatment. Somatic TP53 gene mutation frequently occurs in sporadic osteosarcoma. When arising germline, TP53 mutation leads to Li-Fraumeni syndrome and may result in early life osteosarcoma. The effect of Li-Fraumeni syndrome on the genetic profile of osteosarcoma and the consideration of the syndrome during cancer treatment are topics of current research. CASE PRESENTATION: We report a 25-year-old female with pelvic osteosarcoma refusing continuation of therapy. She interrupted neo-adjuvant chemotherapy according to EURAMOS-1/COSS recommendations and declined local or further adjuvant therapy. Surprisingly, she remained in sustained remission for the osteosarcoma but eventually died from newly diagnosed breast cancer. After establishment of breast cancer, we detected TP53 germline mutation and investigated the osteosarcoma material with array-CGH. CONCLUSION: Genetic examination of the tumour evidenced several copy number alterations with striking differences to previously reported data. We discuss possible influences of the genetic profile on the unusual clinical course and the significance of Li-Fraumeni syndrome for the genetic profile. Specific loss of (proto-) oncogenes might have contributed to the unusual case. Further large-scale genetics of Li-Fraumeni patients combined with detailed clinical data will help to identify specific genetic risk profiles and improve treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13053-021-00202-0. |
format | Online Article Text |
id | pubmed-8527636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85276362021-10-25 Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report Puzik, Alexander Uhl, Markus Ruf, Juri Schumacher, Tilmann Kontny, Udo Hered Cancer Clin Pract Case Report BACKGROUND: Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent whole genome studies revealed distinct mutations in several candidate oncogenes. While clinical parameters stratify osteosarcoma patients in risk groups, genetic profiles have not yet been used to tailor tumour treatment. However, specific copy number alterations seem to have a prognostic impact in osteosarcoma treatment. Somatic TP53 gene mutation frequently occurs in sporadic osteosarcoma. When arising germline, TP53 mutation leads to Li-Fraumeni syndrome and may result in early life osteosarcoma. The effect of Li-Fraumeni syndrome on the genetic profile of osteosarcoma and the consideration of the syndrome during cancer treatment are topics of current research. CASE PRESENTATION: We report a 25-year-old female with pelvic osteosarcoma refusing continuation of therapy. She interrupted neo-adjuvant chemotherapy according to EURAMOS-1/COSS recommendations and declined local or further adjuvant therapy. Surprisingly, she remained in sustained remission for the osteosarcoma but eventually died from newly diagnosed breast cancer. After establishment of breast cancer, we detected TP53 germline mutation and investigated the osteosarcoma material with array-CGH. CONCLUSION: Genetic examination of the tumour evidenced several copy number alterations with striking differences to previously reported data. We discuss possible influences of the genetic profile on the unusual clinical course and the significance of Li-Fraumeni syndrome for the genetic profile. Specific loss of (proto-) oncogenes might have contributed to the unusual case. Further large-scale genetics of Li-Fraumeni patients combined with detailed clinical data will help to identify specific genetic risk profiles and improve treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13053-021-00202-0. BioMed Central 2021-10-20 /pmc/articles/PMC8527636/ /pubmed/34670578 http://dx.doi.org/10.1186/s13053-021-00202-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Puzik, Alexander Uhl, Markus Ruf, Juri Schumacher, Tilmann Kontny, Udo Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report |
title | Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report |
title_full | Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report |
title_fullStr | Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report |
title_full_unstemmed | Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report |
title_short | Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report |
title_sort | unusual course of disease and genetic profile in li-fraumeni syndrome-associated osteosarcoma – a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527636/ https://www.ncbi.nlm.nih.gov/pubmed/34670578 http://dx.doi.org/10.1186/s13053-021-00202-0 |
work_keys_str_mv | AT puzikalexander unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport AT uhlmarkus unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport AT rufjuri unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport AT schumachertilmann unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport AT kontnyudo unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport |